NFLX Form 144: Insider sale notice for 2,600 shares ($3.12M)
Form 144 notice for NFLX shows proposed and recent sales of common stock by Spencer Neumann.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Form 144 notice for NFLX shows proposed and recent sales of common stock by Spencer Neumann. The filing lists a proposed sale of 2,600 shares through Morgan Stanley Smith Barney on 10/01/2025 with an aggregate market value of $3,117,192.00. It also discloses acquisition of those 2,600 shares by exercise of stock options on 10/01/2025 paid in cash. The filing documents three recent sales during the prior three months: 2,600 shares on 09/02/2025, 685 shares on 08/06/2025, and 2,601 shares on 08/01/2025, all by or for Spencer Neumann, with gross proceeds reported for each sale. The filer certifies no undisclosed material adverse information and notes reliance on Rule 10b5-1 where applicable.
Insights
TL;DR: Routine insider option exercise and modest sales; not material relative to outstanding shares.
The filing shows an option exercise and subsequent planned sale of 2,600 shares and records three recent sales totaling 5,886 shares in the past three months. Against 424,926,346 shares outstanding, these transactions represent an immaterial fraction of share count and supply. The disclosure and use of a broker and 10b5-1 sales indicate procedural compliance and pre-arranged trading. For investors, this is a transparency event rather than a signal of company-level stress or major insider reallocation.
TL;DR: Proper Form 144 disclosure and Rule 10b5-1 use, consistent with good governance practices.
The document documents the exercise of options and timely notice of proposed sales via a registered broker. The filer affirms no undisclosed material adverse information and provides dates for past sales and plan adoption where applicable. This filing meets regulatory disclosure expectations; the scale of sales is small relative to outstanding equity, reducing governance or signaling concern.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What recent insider sales are disclosed for Spencer Neumann?
Does the filing indicate any undisclosed material adverse information?
Which broker is handling the proposed sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.